{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:43:13Z","timestamp":1776397393025,"version":"3.51.2"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.radonc.2017.11.024","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T13:19:31Z","timestamp":1513171171000},"page":"48-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins"],"prefix":"10.1016","volume":"126","author":[{"given":"Ruta","family":"Zukauskaite","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian R.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai","family":"Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Sams\u00f8e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen B.B.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elo","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Brink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper G.","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2017.11.024_b0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ctrv.2010.01.004","article-title":"New developments in arc radiation therapy: a review","volume":"36","author":"Palma","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2017.11.024_b0010","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ijrobp.2006.10.029","article-title":"An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658)","volume":"67","author":"Cooper","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.11.024_b0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/0971-6203.44472","article-title":"Tumor delineation: the weakest link in the search for accuracy in radiotherapy","volume":"33","author":"Njeh","year":"2008","journal-title":"J Med Phys"},{"key":"10.1016\/j.radonc.2017.11.024_b0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2017.04.015","article-title":"Inadequate target volume delineation and local-regional recurrence after intensity-modulated radiotherapy for human papillomavirus-positive oropharynx cancer","volume":"123","author":"Chen","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2012.09.015","article-title":"FAZA PET\/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial","volume":"105","author":"Mortensen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.radonc.2015.06.007","article-title":"Primary tumor delineation based on 18FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy","volume":"116","author":"Leclerc","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0035","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1200\/JCO.2015.61.2994","article-title":"Advances in radiotherapy for head and neck cancer","volume":"33","author":"Gregoire","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0040","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1118\/1.4928485","article-title":"A multimodality segmentation framework for automatic target delineation in head and neck radiotherapy","volume":"42","author":"Yang","year":"2015","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2017.11.024_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gr\u00e9goire","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0050","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.clon.2014.05.001","article-title":"Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation","volume":"26","author":"Bayman","year":"2014","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0055","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.oraloncology.2015.08.004","article-title":"Analysis of loco-regional failures in head and neck cancer after radical radiation therapy","volume":"51","author":"De Felice","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0060","first-page":"1","article-title":"Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods","author":"Zukauskaite","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0065","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00066-012-0127-y","article-title":"Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma","volume":"188","author":"Due","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2017.11.024_b0070","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2012.02.042","article-title":"Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma","volume":"85","author":"Raktoe","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.11.024_b0075","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.radonc.2017.07.017","article-title":"Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions","volume":"124","author":"Mohamed","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0080","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3109\/0284186X.2015.1063780","article-title":"Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial","volume":"54","author":"Hansen","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2006.03.006","article-title":"Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-margins","volume":"78","author":"Suzuki","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00066-016-0998-4","article-title":"Open source deformable image registration system for treatment planning and recurrence CT scans: validation in the head and neck region","volume":"192","author":"Zukauskaite","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2017.11.024_b0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.radonc.2016.02.006","article-title":"Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent \u2013 a population based study from the DAHANCA group","volume":"118","author":"Lyhne","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semradonc.2008.09.008","article-title":"Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer","volume":"19","author":"Eisbruch","year":"2009","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1148\/radiol.2331030660","article-title":"Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen","volume":"233","author":"Daisne","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2017.11.024_b0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ctro.2016.08.001","article-title":"Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans","volume":"1","author":"Hansen","year":"2016","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/coa.12674","article-title":"Outcomes of intensity-modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma \u2013 a European single institution analysis","volume":"42","author":"Bird","year":"2017","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.radonc.2017.11.024_b0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.radonc.2013.03.002","article-title":"A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach","volume":"106","author":"Leclerc","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0125","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ijrobp.2008.01.027","article-title":"Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma","volume":"72","author":"Sanguineti","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.11.024_b0130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.radonc.2014.06.001","article-title":"Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake","volume":"111","author":"Due","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0135","series-title":"Head and neck cancer recurrence Evidence-based, multidisciplinary management","first-page":"7","article-title":"Molecular biology of recurrence","author":"Harrington","year":"2012"},{"key":"10.1016\/j.radonc.2017.11.024_b0140","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2419","article-title":"Exploring the role of cancer stem cells in radioresistance","volume":"8","author":"Baumann","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2017.11.024_b0145","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/0284186X.2015.1117136","article-title":"Failure pattern and salvage treatment after radical treatment of head and neck cancer","volume":"55","author":"Pagh","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13014-016-0678-7","article-title":"Methodology for analysis and reporting patterns of failure in the Era of IMRT: head and neck cancer applications","volume":"11","author":"Mohamed","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijrobp.2009.01.037","article-title":"Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer","volume":"76","author":"Caudell","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.11.024_b0160","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/hed.23532","article-title":"Long-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancer","volume":"36","author":"Chen","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2017.11.024_b0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13014-015-0345-4","article-title":"Assessment and topographic characterization of locoregional recurrences in head and neck tumours","volume":"10","author":"Ferreira","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2011.03.004","article-title":"Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck \u2013 a systematic review and meta-analysis","volume":"100","author":"Overgaard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0175","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3109\/0284186X.2014.992547","article-title":"Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study","volume":"54","author":"Bentzen","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0180","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3109\/0284186X.2014.990109","article-title":"Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study","volume":"54","author":"Servagi-Vernat","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.radonc.2017.08.010","article-title":"Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging","volume":"124","author":"Lock","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0190","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","article-title":"Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis","volume":"18","author":"Lacas","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0195","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ijrobp.2015.12.380","article-title":"Elective nodal irradiation and patterns of failure in head and neck cancer after primary radiation therapy","volume":"94","author":"Kjems","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.11.024_b0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2011.12.010","article-title":"Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03","volume":"103","author":"Toledano","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0205","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.ijrobp.2011.03.029","article-title":"Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes","volume":"82","author":"Lok","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.11.024_b0210","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.0973","article-title":"Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques","author":"Leeman","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(00)00202-4","article-title":"Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience","volume":"56","author":"Gregoire","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0220","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.radonc.2017.11.024_b0225","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00405-016-4413-7","article-title":"Recurrent oropharyngeal cancer after organ preserving treatment: pattern of failure and survival","volume":"274","author":"de Ridder","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.radonc.2017.11.024_b0230","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ijrobp.2010.09.038","article-title":"Evaluation of microscopic disease in oral tongue cancer using whole-mount histopathologic techniques: implications for the management of head-and-neck cancers","volume":"82","author":"Campbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.11.024_b0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2017.02.005","article-title":"Modality-specific target definition for laryngeal and hypopharyngeal cancer on FDG-PET, CT and MRI","volume":"123","author":"Ligtenberg","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.11.024_b0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2017.09.019","article-title":"Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy","volume":"126","author":"Hansen","year":"2018","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017327445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017327445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T18:04:08Z","timestamp":1547748248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814017327445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0167814017327445"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2017.11.024","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2017.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}